Publications by authors named "Radka Graf"

Claim this Profile
R
Reproducibility via coordinated standardization: a multi-center study in a Shank2 genetic rat model for Autism Spectrum Disorders.
María Arroyo-Araujo, Radka Graf, Martine Maco, Elsbeth van Dam, Esther Schenker

Sci Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The location discrimination reversal task in mice is sensitive to deficits in performance caused by aging, pharmacological and other challenges.
Radka Graf, Jami L Longo, Zoë A Hughes

J Psychopharmacol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperactivity and Hypermotivation Associated With Increased Striatal mGluR1 Signaling in a Shank2 Rat Model of Autism.
Meera E Modi, Julie M Brooks, Edward R Guilmette, Mercedes Beyna, Radka Graf

Front Mol Neurosci· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel triazines as potent and selective phosphodiesterase 10A inhibitors.
Michael S Malamas, Hans Stange, Rudolf Schindler, Hans-Joachim Lankau, Christian Grunwald, Radka Graf

Bioorg Med Chem Lett· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly potent, selective, and orally active phosphodiesterase 10A inhibitors.
Michael S Malamas, Yike Ni, James Erdei, Hans Stange, Rudolf Schindler, Radka Graf

J Med Chem· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
Simon N Haydar, Heedong Yun, Patrick M Andrae, James Mattes, Jean Zhang, Radka Graf

J Med Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.
Robert H Ring, Lee E Schechter, Sarah K Leonard, Jason M Dwyer, Brian J Platt, Radka Graf

Neuropharmacology· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.
Julie A Brennan, Radka Graf, Steven M Grauer, Rachel L Navarra, Claudine M Pulicicchio

J Pharmacol Exp Ther· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?
Sheree F Logue, Steven M Grauer, Janet Paulsen, Radka Graf, Noel Taylor

Mol Cell Neurosci· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia.
Steven M Grauer, Virginia L Pulito, Rachel L Navarra, Michele P Kelly, Cody Kelley, Radka Graf

J Pharmacol Exp Ther· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia.
David P Rotella, Geraldine R McFarlane, Alexander Greenfield, Cristina Grosanu, Albert J Robichaud, Radka Graf

Bioorg Med Chem Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics.
Steven M Grauer, Radka Graf, Rachel Navarra, Amy Sung, Sheree F Logue

Psychopharmacology (Berl)· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
Feng Liu, Steve Grauer, Cody Kelley, Rachel Navarra, Radka Graf

J Pharmacol Exp Ther· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 5-HT(2C) receptor agonist WAY-163909 decreases impulsivity in the 5-choice serial reaction time test.
Rachel Navarra, Thomas A Comery, Radka Graf, Sharon Rosenzweig-Lipson, Mark Day

Behav Brain Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
Rachel Navarra, Radka Graf, Youping Huang, Sheree Logue, Thomas Comery

Prog Neuropsychopharmacol Biol Psychiatry· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis